Automated Blood Processing Equipment Market Growth Drivers and Challenges:
Growth Drivers
- Increase in Chronic Diseases Globally - The majority of the global disease burden is accounted for by the rise in the burden of chronic illness over time. While the epidemiology of chronic disease burden differs by nation, most industrialized and developing nations have significant chronic disease burden rates. The same procedures primary care physicians use to test for depression or diabetes should also be used to screen for sleep issues. Access to reasonably priced, successful treatments for sleep problems, such as cognitive behavioral therapy, should be made possible by governments and healthcare systems. This is particularly crucial for blacks, American Indians, Alaska Natives, and others with lower incomes. Studies reveal that racial or ethnic minorities experience more sleep disturbances and specific sleep disorders than other racial or ethnic groups, yet they also receive fewer diagnoses and less treatment.
- Increasing Campaign for Blood Donation Programs - All of Lifeblood's donors are urged to become social media celebrities. Their website provides a four-step strategy to help donors spread the word about the need for 33,000 contributions each week to help meet the need for products made from blood and plasma. The New York Blood Center is aware of the critical role that community influencers play in bringing awareness to the ongoing need for blood. To guarantee the success of their influencers, they have developed an online resource that offers social media postings, photos, videos, brochures, and more. Physicians worldwide utilize blood supplies to treat a wide range of illnesses, including cancer, anemia, heart, kidney, and stomach disorders, traumatic injuries sustained in emergencies, natural disasters, and accidents, among others.
- Increasing Prevalence of Patients Experiencing Chemotherapy - It is predicted that there will be 26 million new cases of cancer in 2040, the majority of which will occur in low- and middle-income nations. In 2018, there were about 17 million new cases of cancer. The study projects that by 2040, two-thirds (67%) of patients in need of chemotherapy will reside in these nations, as will 75% of the 5.2 million more patients who would require the treatment by then.
Challenges
- Higher Rate of Costs of Automated Blood Collection Devices- Blood collection tubes are made of sterile plastic and have a colored rubber stopper that seals the tube to produce a vacuum that makes it simpler to remove a certain volume of liquid. Serum separator tubes are most frequently used for venipuncture blood sample collection. Additives intended to stabilize and preserve the specimen before analytical testing may be present in some tubes. Rubber stoppers, which are safety-engineered closures, come in a range of draw volumes, labeling options, and stopper colors for tubes.
- Blood cultures (BCs), still regarded as the gold standard for pathogen identification and susceptibility profile assessment, are used to detect pathogens, bacteria, or fungi responsible for BSI diagnosis. The proper collection and prompt delivery of BCs have a significant impact on the diagnostic yield. Additionally, safety during BC sampling must be addressed with the right protocols and by involving personnel who have received specific training.
- Lack of Knowledge in People
- Increase in Pollution
Automated Blood Processing Equipment Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
7.7% |
|
Base Year Market Size (2025) |
USD 2.23 billion |
|
Forecast Year Market Size (2035) |
USD 4.68 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of automated blood processing equipment is evaluated at USD 2.38 billion.
The global automated blood processing equipment market size exceeded USD 2.23 billion in 2025 and is set to expand at a CAGR of around 7.7%, surpassing USD 4.68 billion revenue by 2035.
The North America automated blood processing equipment market will dominate around 35% share by 2035, driven by increasing technological advancements in blood processing.
Key players in the market include Nipro Medical Corporation, Business PlanningMain Product OfferingsFinancial ExecutionMain Performance IndicatorsBD, Terumo BCT Inc., Fresenius KABI AG, Grifols S.A., Greiner AG, Quest Diagnostics Incorporated, Macopharma, SARSTEDT AG & Co. KG, ICU Medical, Inc.